Press Release - Company Data

Theratechnologies Announces Financial Results for Second Quarter of 2014
Posted 2014-07-09 00:23NAI Editing
today announced its financial results for the second quarter ended May 31, 2014. Second quarter 2014 financial highlights

Theratechnologies to Receive 4.1 Million Dollar Payment from Revenue Canada
Posted 2014-06-25 00:17NAI Editing
today announced that it will receive a refund of approximately $4.1 million from the Canada Revenue Agency after settling a dispute over its claims of refundable investment tax credits related to its

Additional Update on Availability of EGRIFTA(R) (tesamorelin for injection) in the United States
Posted 2014-05-22 23:39NAI Editing
announced today that following further communications between the United States Food and Drug Administration (FDA) and the Company it is revisiting the information provided in its May 20, 2014 press r

Theratechnologies Announces Financial Results for Fiscal Year 2013
Posted 2014-02-27 00:23NAI Editing
today announced its financial results for the year ended November 30, 2013. Fiscal 2013 Highlights

Theratechnologies Regains U.S. Marketing Rights to EGRIFTA(R)
Posted 2013-12-12 23:39NAI Editing
today announced that it has reached an agreement with EMD Serono to regain all rights under the current collaboration and licensing agreement entered into in 2008 with EMD Serono, including commercial

Theratechnologies Obtains US Patent for Improving Cognitive Function with Tesamorelin in Patients Suffering from MCI
Posted 2013-07-10 23:45NAI Editing
today announced that the US Patent and Trademark Office (USPTO) has issued Patent No.

Theratechnologies Obtains US Patent for Improving Cognitive Function with Tesamorelin in Patients Suffering from MCI
Posted 2013-07-10 23:42NAI Editing
today announced that the US Patent and Trademark Office (USPTO) has issued Patent No.

Theratechnologies Obtains US Patent for Improving Cognitive Function with Tesamorelin in Patients Suffering from MCI
Posted 2013-07-10 23:42NAI Editing
today announced that the US Patent and Trademark Office (USPTO) has issued Patent No.

Theratechnologies Announces Financial Results for Second Quarter of 2013
Posted 2013-07-09 23:44NAI Editing
today announced its financial results for the second quarter ended May 31, 2013. Second quarter financial highlights

Theratechnologies Inc./Request for Reconsideration in Canada: Meeting With Scientific Advisory Committee Authorized
Posted 2013-07-07 23:35NAI Editing
today announced that it has received confirmation from Health Canada that it will be meeting with a scientific advisory committee on August 23, 2013 as part of the request for reconsideration process